ESR1 and benign neoplasm: Compared with miRNA expression levels, an opposite trend in the expression pattern of the ESR1 target gene was observed in this study, with a significantly lower expression of ESR1 mRNA in malignant CMTs compared with both the non-neoplastic mammary gland and benign tumors.